NIRS in Congenital Heart Defects - Correlation With Echocardiography

ConditionsCongenital Heart Defect Single-ventricle Coarctation of Aorta Atrioventricular Canal Hypoplastic Left Heart Transposition of Great Vessels Interrupted Aortic Arch Tricuspid Atresia Pulmonary Atresia Aortic Atresia Tetralogy of Fallot

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age0-7

SponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre

About this trial

Neonatal patients with congenital heart defects (CHD) have changing physiology in the context of transitional period. Patients with CHD are at risk of low perfusion status or abnormal pulmonary blood flow. Near infrared spectroscopy has been used in neonatal intensive care units (NICU) to measure end-organ perfusion. The investigator plan on monitoring newborns with CHD admitted to the NICU with NIRS and echocardiography during the first week of life and correlate measures of perfusion from Dopplers to cerebral and renal NIRS.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

NIRS evaluation

Treatment groups

No treatment groups listed

Locations

Mcgill University Health CentreH4A 3J1, MontrealQuebec, Canada

Sponsors and collaborators

McGill University Health Centre/Research Institute of the McGill University Health Centre

Lead sponsor

Medtronic

Collaborator

Source ClinicalTrials.gov